CRVS (STOCKS)
Corvus Pharmaceuticals, Inc.
$14.573600
-0.526400 (-3.49%)
Prev close: $15.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard A. Miller
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,274.16M
- Employees
- 31
- P/E (TTM)
- -29.97
- P/B (TTM)
- 18.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $42.97M |
| Depreciation and Amortization | $100.00K |
| Research and Development | $33.72M |
| Other Operating Expenses | $9.15M |
| Operating Income/Loss | -$42.97M |
| Income/Loss Before Equity Method Investments | -$13.33M |
| Income/Loss From Continuing Operations After Tax | -$13.33M |
| Income/Loss From Continuing Operations Before Tax | -$13.33M |
| Income/Loss From Equity Method Investments | -$1.96M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$15.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.19 |
| Diluted Earnings Per Share | -$0.53 |
| Basic Average Shares | 78,964,842 |
| Diluted Average Shares | 79,742,685 |
| Assets | $71.12M |
| Current Assets | $58.21M |
| Cash | $56.80M |
| Other Current Assets | $1.41M |
| Noncurrent Assets | $12.91M |
| Fixed Assets | $220.00K |
| Other Non-current Assets | $12.69M |
| Liabilities | $9.91M |
| Current Liabilities | $9.38M |
| Accounts Payable | $2.49M |
| Wages | $641.00K |
| Other Current Liabilities | $6.25M |
| Noncurrent Liabilities | $534.00K |
| Equity | $61.21M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $61.21M |
| Liabilities And Equity | $71.12M |
| Net Cash Flow From Operating Activities | -$32.80M |
| Net Cash Flow From Operating Activities, Continuing | -$32.80M |
| Net Cash Flow From Investing Activities | -$7.80M |
| Net Cash Flow From Investing Activities, Continuing | -$7.80M |
| Net Cash Flow From Financing Activities | $36.43M |
| Net Cash Flow From Financing Activities, Continuing | $36.43M |
| Net Cash Flow | -$4.16M |
| Net Cash Flow, Continuing | -$4.16M |
| Comprehensive Income/Loss | -$14.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$14.89M |
| Other Comprehensive Income/Loss | $392.00K |